Cargando…
Ventricular assist device for a coronavirus disease 2019‐affected heart
Coronavirus disease 2019 (COVID‐19) is challenging the care for cardiovascular patients, resulting in serious consequences with increasing mortality in pre‐diseased heart failure patients. In the current state of the pandemic, the physiopathology of COVID‐19 affecting pre‐diseased hearts and the man...
Autores principales: | Rassaf, Tienush, Totzeck, Matthias, Mahabadi, Amir A., Hendgen‐Cotta, Ulrike, Korste, Sebastian, Settelmeier, Stephan, Luedike, Peter, Dittmer, Ulf, Herbstreit, Frank, Brenner, Thorsten, Klingel, Karin, Hasenberg, Mike, Walkenfort, Bernd, Gunzer, Matthias, Schlosser, Thomas, Weymann, Alexander, Kamler, Markus, Schmack, Bastian, Ruhparwar, Arjang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753611/ https://www.ncbi.nlm.nih.gov/pubmed/33219613 http://dx.doi.org/10.1002/ehf2.13120 |
Ejemplares similares
-
Increased bleeding risk with phosphodiesterase‐5 inhibitors after left ventricular assist device implantation
por: Jakstaite, Aiste‐Monika, et al.
Publicado: (2021) -
Structural components for the development of a heart failure network
por: Luedike, Peter, et al.
Publicado: (2022) -
Feasibility of a Novel Transcatheter Valve Repair System to Treat Tricuspid Regurgitation in ccTGA
por: Luedike, Peter, et al.
Publicado: (2021) -
Central extracorporeal circulatory life support (cECLS) in selected patients with critical cardiogenic shock
por: Schmack, Leonie, et al.
Publicado: (2023) -
PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial Infarction
por: Michel, Lars, et al.
Publicado: (2022)